Atkt Viewpoints: Air Pollution Is Causing Heart Attacks; Legalizing Marijuana Will Hurt Drug Companies Profits
Rep <a href=https://www.owala-waterbottle.ca>owala water bottle</a> . Elijah Cummings Has Been A Thorn In Pharma Side For Years. Now He Poised To Take Over Powerful Oversight Committee.Rep. Elijah Cummings D-Md. is expected to take up the gavel of the House Oversight and Government Reform Committee, which will give him authority to haul drugmakers in front of Congress to question them on high prices. Meanwhile, pharmaceutical companie <a href=https://www.hydrojug.ca>hydrojug canada</a> s are already getting nervous about a potentially relationship between House Democrats and President Donald Trump over the issue.Stat:Elijah Cummings Sparred With Martin Shkreli And Mylans CEO. Now Hes Got A Gavel To Take On PharmaHe accused Valeant Pharmaceuticals of obstructing a congressional investigation into its pricing practices. He called out Biogen for charging so much for a multiple sclerosis drug that the government holds a patent on. And he famously scolded a smirking Martin Shkreli during a hearing, saying, Its not funny, Mr. Shkreli. People are dying. For years, Elijah Cummings has been a persistent, if forceless, thorn in the pharmaceuti <a href=https://www.stanley-cups.pl>stanley cup</a> cal industrys side. Now, though, Congress pharma critic-in-chief will be armed with the authority of a powerful committee chairmanship at a time when lawmakers in both parties are squeezing drug companies more than ever before. Joseph, 11/9 The Hill:Dem Overtures To Trump On Drug Pricing Worry Pharma聽The Democratic takeover of the House is giving new life to efforts to fight high drug prices with bipartisan action, a worrying prospect for the Ifpg Los Angeles Times Examines Increase in Caesarean Births, Related Rise in Risk, Cost
Friday, Nov 10 2006World Health Assembly Elects Former Hong Kong <a href=https://www.cups-stanley-cups.com.de>stanley germany</a> Health Director Chan as WHO Director GeneralThe World Health Organization s World Health Assembly on Thursday at a one-day special session elected Margaret Chan, a former health director from Hong Kong and the agency s top infectious disease official, to be the organization s next director general, the Wall Street Journal reports McKay, Wall Street Journal, 11/10 . WHO s executive board on Wednesday nominated Chan for the position of director general to replace Lee Jong-wook, according to diplomats. Lee died in May, two years before his term ended. Chan is the first Chinese national to be selected for a prominent U.N. post, according to delegates. The 34-member board s nomination was submitted to the World Health Assembly, which needed to vote by a two-thirds majority to approve Chan s nomination. Chan s term will run until July 2012. During her campaign for WHO director general, Chan -- who has worked at WHO since 2003 -- said that if she were selected, she would focus on diseases such as HI <a href=https://www.stanley-cup.at>stanley austria</a> V/AIDS and tuberculosis. Chan also has said that she will address women s health issues and the migration of skilled health care workers from developing countries Kaiser Daily HIV/AIDS Report, 11/9 . Chan in her acceptance speec <a href=https://www.adidassamba.com.de>adidas samba og</a> h pledged to focus her efforts on women worldwide and to improve health conditions for Africans, who carry an enormous and disproportionate burden of ill health and premature death, she said Xinh |
 |
| 2026/01/17(Sat) 14:48 |
|